Yang Zhou

19A, Yuquan Road
Yuquan, 100049, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Decoding the SHOX2 methylation-expression paradox in lung adenocarcinoma: Dual-regulatory methylation patterns drive oncogenic activation and prognostic relevance.

Decoding the SHOX2 methylation-expression paradox in lung adenocarcinoma: Dual-regulatory methylation patterns drive oncogenic activation and prognostic relevance.

Journal: Cancer letters

Published: September 06, 2025

Scoring Reliability of c-Met Immunohistochemical Assays in Lung Adenocarcinoma.

Scoring Reliability of c-Met Immunohistochemical Assays in Lung Adenocarcinoma.

Journal: Laboratory investigation; a journal of technical methods and pathology

Published: August 15, 2025

Presence of microscopic skipping growth pattern correlated with KRAS or GNAS mutations in pulmonary mucinous adenocarcinoma.

Presence of microscopic skipping growth pattern correlated with KRAS or GNAS mutations in pulmonary mucinous adenocarcinoma.

Journal: Pathology, research and practice

Published: June 07, 2025

Clinical Validation of a Targeted RNA-Sequencing Assay for Driver Gene Alteration Detection in Non-Small Cell Lung Cancer.

Clinical Validation of a Targeted RNA-Sequencing Assay for Driver Gene Alteration Detection in Non-Small Cell Lung Cancer.

Journal: Molecular diagnosis & therapy

Published: February 17, 2025

Characteristics of the immune microenvironment and their clinical significance in lung adenocarcinoma patients with different ALK fusion variants.

Characteristics of the immune microenvironment and their clinical significance in lung adenocarcinoma patients with different ALK fusion variants.

Journal: Translational lung cancer research

Published: August 04, 2024

IL-1 receptor-associated kinase 3 (IRAK3) in lung adenocarcinoma predicts prognosis and immunotherapy resistance: involvement of multiple inflammation-related pathways.

IL-1 receptor-associated kinase 3 (IRAK3) in lung adenocarcinoma predicts prognosis and immunotherapy resistance: involvement of multiple inflammation-related pathways.

Journal: Translational lung cancer research

Published: May 02, 2024

Strophanthidin Induces Apoptosis of Human Lung Adenocarcinoma Cells by Promoting TRAIL-DR5 Signaling.

Strophanthidin Induces Apoptosis of Human Lung Adenocarcinoma Cells by Promoting TRAIL-DR5 Signaling.

Journal: Molecules (Basel, Switzerland)

Published: January 17, 2024

UniPET: A universal network for high-quality PET image denoising across varied dose reduction factors.

UniPET: A universal network for high-quality PET image denoising across varied dose reduction factors.

Journal: Medical image analysis

Published: January 09, 2024

Design of Miniature Ultrawideband Active Magnetic Field Probe Using Integrated Design Idea.

Design of Miniature Ultrawideband Active Magnetic Field Probe Using Integrated Design Idea.

Journal: Sensors (Basel, Switzerland)

Published: April 20, 2023

Monoacylglycerol Lipase Knockdown Inhibits Cell Proliferation and Metastasis in Lung Adenocarcinoma.

Monoacylglycerol Lipase Knockdown Inhibits Cell Proliferation and Metastasis in Lung Adenocarcinoma.

Journal: Frontiers in oncology

Published: May 06, 2020

Systemic immune-inflammation index (SII) is useful to predict survival outcomes in patients with surgically resected non-small cell lung cancer.

Systemic immune-inflammation index (SII) is useful to predict survival outcomes in patients with surgically resected non-small cell lung cancer.

Journal: Thoracic cancer

Published: December 20, 2018

Discovery and validation of potential urinary biomarkers for bladder cancer diagnosis using a pseudotargeted GC-MS metabolomics method.

Discovery and validation of potential urinary biomarkers for bladder cancer diagnosis using a pseudotargeted GC-MS metabolomics method.

Journal: Oncotarget

Published: November 15, 2016

Showing 1-12 of 17

Last Updated: 09/26/2026